Abstract
Backgrounds/Aims
The course of severe acute pancreatitis (SAP) complicated by hemorrhage is associated with poor outcome.
Methods
Twenty-four (13%) out of 183 cases of SAP had hemorrhagic complications- 12 intraabdominal & 12 intraluminal, 13 had major & 11 had minor and 16 had de-novo & 8 post-surgical bleeding. The mean duration of pancreatitis prior to bleeding was 27±27.2 days.
Results
Predictors of haemorrhage on univariate analysis were delayed admission (0.037), more than one organ failure (p=0.008), presence of venous thrombosis (p=0.033), infective necrosis (0.001) and systemic sepsis – bacterial (0.037) & fungal (p=0.032). On multivariate analysis infected necrosis (OR=11.82) and presence of fungal sepsis (OR=3.73) were the significant factors. Patients presenting with more than one organ failure and bacterial sepsis had borderline significance on multivariate analysis. Need for surgery (50% vs. 12.6%), intensive care stay (7.4±7.9 vs. 5.4±5.2 days) and mortality (41.7% vs. 10.7%) were significantly higher in patients who suffered haemorrhage. Seven of the 13 with major bleeding had pseudoaneurysms-4 were embolized, 4 needed surgery including 1 embolization failure. Seven with intraabdominal bleeding required surgical intervention, 2 had successful embolization and 3 had expectant management. CT severity index and surgical intervention, were significantly associated with intraabdominal bleeding. Organ failure, presence of pseudoaneurysm and surgical intervention were associated with major bleeding.
Severe Acute pancreatitis (SAP) carries a mortality of 15-20%.1-3 Although gastrointestinal (GI) bleed is not considered as organ failure in the revised Atlanta classification,4 still the consequences associated with it can sometimes be detrimental. Due to the rarity of this complication, there has been a lot of variability in its reporting. The reported incidence is 1-23%.5-9 However, whenever this complication is encountered, it can be fatal in one- third to half of the cases.5-7 Haemorrhage in the peripancreatic area further complicates the course of necrosis and increases mortality.5-9 Haemorrhage can arise secondary to erosion of the vascular wall, formation of pseudoaneurysms or microvascular ischaemic complications, spleno-porto-mesenteric venous thrombosis causing oesophagogastric varices5,6 and following surgical debridement.5,10-12 Severe inflammation and activated enzymes which leak into the retroperitoneum in SAP can digest the viscus and vascular structure, including the relatively resistant arterial wall. This leads to acute erosion, disruption, or wall weakening and pseudoaneurysm formation which might eventually rupture and bleed.5,6,8,10,12 Pancreatic necrosis, abscess and pseudocysts may produce similar damage to the vasculature. In addition to pancreatic debridement, timing of surgery and surgical technique have also been identified as risk factors for the occurrence of haemorrhage. 5,8,10,12
There is paucity of literature on the haemorrhagic complications arising as a result acute pancreatitis, so the present study was planned to classify and assess the outcome of the course of severe acute pancreatitis complicated by haemorrhage.
From January 2005 to December 2012, patients with acute pancreatitis were reviewed - prospectively (June 2011 to December 2012) and retrospectively (January 2005 to May 2011) - at Postgraduate Institute of Medical Education and Research, Chandigarh, a tertiary care hospital in India. The study was approved by the Institute ethics committee. Informed consent was taken from all the patients prior to enrolment in the prospective group. Acute pancreatitis was diagnosed by means of history, clinical examination, and radiological examination. The diagnosis of severe acute pancreatitis was established as per the revised Atlanta classification4 as the presence of persistent organ failure (organ failure lasting greater than 48 hours).
The patients were evaluated for demographic data, etiology, clinical presentations and radiological details. The patients with organ failure were given appropriate support. Periodic evaluation was performed with hematological, biochemical, microbiological and imaging parameters. Antibiotics were routinely used in all the patients. Nutrition was instituted once the patients were stabilized. Enteral route was preferred wherever possible. Patients deteriorating on conservative management were managed with radiological guided percutaneous catheter drainage. Surgical necrosectomy was reserved for patients not improving after percutaneous drainage. During the course of hospitalization the patients were closely observed for the development of haemorrhagic complications which were classified as below. Morbidity and mortality associated with haemorrhage occurring in pancreatitis was recorded.
i) Site
a) Luminal as defined by the presence of hematemesis, melena or blood in nasogastric tube.
b) Extraluminal or Intraabdominal haemorrhage: blood emanating through drains placed percutaneously or at operation; or development of unexplained hemodynamic instability or CECT findings consistent with presence of contrast extravasation into the peripancreatic cyst, peritoneal cavity or retroperitoneum.
ii) Timing
a) De novo: prior to surgical intervention during the course of illness.
b) Post-surgical: following surgical interventions.
iii) Severity
a) Major haemorrhage: as defined by an acute reduction in haemoglobin concentration of at least 2 g/dl in a patient with overt bleeding and/or hemodynamic instability in an otherwise stable patient, in whom other causes of hemodynamic instability, such as septic shock or abdominal compartment syndrome, seemed unlikely.
b) Minor haemorrhage: not fitting into the category of major haemorrhage.
Luminal haemorrhage was evaluated with endoscopy while patients with extraluminal and/or post operative bleeding as well as major luminal bleeding underwent computerized tomogram (CT) angiogram. Further management was governed by the ability to localize. Patients, in whom bleeding was localized, were managed either with embolization or surgery depending on the hemodynamic stability. Patients, in whom bleeding was not localized on CT angiogram were evaluated for severity.
All patients with severe bleeding not localized on CT angiogram were subjected to digital subtraction angiogram (DSA). Those with minor bleeding and not localized on CT angiogram were closely observed for recurrence of bleeding. In case of recurrent bleeding DSA was carried out.
Descriptive statistics were used. Data was expressed as mean±SD or mean (range) as appropriate. Mann Whitney U test was used to evaluate ordinal data like CTSI. Chi square test was used for analysis of nominal data. Factors which were found significant on univariate analysis were entered into multivariate logistic regression analysis. Statistical significance was set at <0.05.
A total of 183 patients of severe acute pancreatitis (SAP) were evaluated during the study period - 86 prospectively and 97 retrospectively. The mean age was 39.6±13.0 years with a sex ratio of (M:F) 2.58:1. Etiology was alcohol in 92 (49.7%) and biliary in 50 (27.3%). Mean duration between the onset of symptoms and admission to a tertiary care facility was 12.51±17.09 (1-31) days. Mean APACHE II score at admission was 6.09± 4.13 and mean CTSI was 8.45±1.47. At presentation to our hospital, 88 (48.09%) patients had organ failure. The mean number of organ failure at admission was 0.76. However, during the course of hospitalization, all patients went on to develop organ failure. Infected pancreatic necrosis was seen in 47 (25.68%), blood stream bacterial and fungal infections were observed in 45 (24.59%) and 12 (6.56%) respectively. Venous thrombosis was observed in 21 (11.48%). Pseudoaneurysm of peripancreatic vasculature was seen in nine (4.92%). Percutaneous drainage was required in 96 (52.46%) patients. Surgical interventions were required in 32 (17.49%) patients. Overall mortality rate was 14.75% (27). Mean ICU stay and hospital stay was 5.80+5.61 days and 18.91+12.82 days.
Although, all luminal bleedings were localized by endoscopy, but those who had major bleeding were subjected for CT angiography in addition. Seven (58%) had false luminal bleed arising as a result of – intraluminal rupture of pseudoaneurysm in 4 and spontaneous rupture of pancreatic collection into hollow viscus in 3 (Fig. 2). Haemorrhage associated with the former was massive, while the later was self limiting.
Extraluminal bleeding could not be localized in seven (58%) patients.
CT angiogram was done in 16 patients showed pseudoaneurysm in 8 (7 ruptured) and diffuse contrast extravasation without getting localized in 1. Pseudoaneurysm involved splenic artery in 5 and one each of gastro-duodenal (without rupture), superior mesenteric and left gastric arteries.
Minor luminal bleeding with intraluminal source seen in three patients was managed by endoscopic therapy (sclero, heater probe and argon plasma coagulation). False luminal bleed due to rupture of pancreatic collection observed in three patients was self limiting and did not require any intervention for bleeding, however, two patient – one with duodenal rupture mandated surgery because of multiple duodenal perforations and worsening sepsis and another with colonic rupture needed surgery due to worsening sepsis.
Both cases of major luminal bleeding due to colon ischemia underwent colectomy (1 segmental & 1 subtotal). Two of the three patients with pseudoaneurysm mandated surgical ligation and necrosectomy while one developed postoperative pseudoaneurysm was managed by DSA and embolization.
Two cases of de-novo minor extraluminal bleeding were due to – pseudoaneurysm in one and hyerdense collection on CT in another. The former was managed by embolization and later had expectant management. Two patients with post-surgical with minor bleeding from drain were not localized on CT angiogram and were closely observed, however, both of them did not require any further intervention.
De-novo major extraluminal bleeding due to pseudoaneurysms was seen in two patients, which was successfully embolized in one, however another had re-bleeding and required surgical intervention. Two patients with bleeding from PCD could not be localized on angiogram, and were operated upon. Both of them had venous ooze and underwent packing and temporary abdominal closure.
One of the two patients with pseudoaneurysms post- surgical necrosectomy had major extraluminal bleeding and was managed by surgical ligation while another one died of exsanguination before any intervention could be done. Other two with diffuse venous bleeding were managed by packing and temporary abdominal closure.
Overall, 12 patients were operated upon – control of haemorrhage in 8 and control of sepsis in 4. Mortality in operated patients was significantly higher [7 (58%) versus 2 (17%), p=0.044, OR 6.39, CI 1.01-59.46] when compared to those not operated upon.
On univariate analysis delayed referral to a tertiary care facility, higher APACHE II score, more number of organ failure at admission, presence of venous thrombosis, presence of infective necrosis and occurrence of systemic sepsis during the course of illness were the predictors of bleeding complications (Table 1). On multivariate analysis presence of infected necrosis (OR 11.82) and presence of fungal sepsis (OR 3.73) were significant factors for te occurrence of haemorrhage. More number of organ failure at admission and presence of bacterial sepsis had borderline significance with haemorrhagic complications on multivariate analysis.
Occurrence of pseudoaneurysms, need for surgical intervention, intensive care stay and mortality were significantly higher on univariate and multivariate analysis in patients who had haemorrhage.
Luminal versus extraluminal (abdominal) bleeding: Patients with extraluminal bleeding had more severe pancreatitis and higher need for surgical intervention (Table 2). There was a trend towards delayed presentation of abdominal bleeding.
Major versus minor bleeding: patients with major bleeding had lesser mean number of organ failure, higher incidence of pseudoaneurysms, and a higher need for surgery (Table 3).
De-novo versus post-surgical bleed: Both the groups were comparable in terms of severity and need for interventions (Table 4).
The present study has proposed the classification system for haemorrhage associated with acute pancreatitis. The need for intervention can be based on the algorithm developed as per the proposed classification. Although bleeding associated with pancreatitis should be addressed with aggressive management, but we observed a small subset of patients with non localized minor bleeding who could be managed expectantly. The intervention options for such patients are very limited due to the nature and non-localization. Another interesting group of patients we observed was the ones with rupture of pancreatic collection into the hollow viscus. These patients had minor intra-luminal bleed followed by clinical improvement of the symptoms. However, the need of further intervention if at all required was due to the infective complications arising as a result of contamination of the pancreatic collection by the GI tract or due to the development of GI fistulae.
Occurrence of haemorrhage during the course of acute pancreatitis is an ominous sign as it sharply increases the mortality. About one-third to half the patients experiencing haemorrhage die after this catastrophic complcation.5,6,9,12 There has been a lot of variability in reporting the incidence of haemorrhage associated with pancreatitis due to the rarity of this complication and varied presentations.5-12 Most of the large reports on pseudoaneurysms associated with pancreatitis include both acute and chronic cases.5,13-18 EPAMI (Epidemiología de la Pancreatitis Aguda en Medicina Intensiva) Study group has reported 11% incidence of abdominal haemorrhage in critically ill patients with pancreatitis across 46 intensive care units from Spain and Latin America.12 Wei at al.9 in a report from China reported 15% incidence of haemorrhage with acute necrotizing pancreatitis. Tang et al.19 encountered 11.5% incidence of haemorrhage a study of more than 500 patients of acute pancreatitis. However, the incidence of haemorrhage in severe and moderately severe pancreatitis was 17%. In the present study we report 13% incidence of haemorrhage in severe acute pancreatitis.
The development of haemorrhage has been linked to disease severity of illness.7-9,12,19 We observed a higher mean number of organ failure in patients experiencing haemorrhage. Others have also observed higher severity scoring indices and organ failure associated with the occurrence of haemorrhage in acute pancreatitis. A recent study (MRI) reported 7.7% and 19.2% incidence of haemorrhage respectively in mild and severe pancreatitis as defined by APACHE II score.19 Labarca et al.12 in addition observed increasing age and gall stone etiology as the risk factors on multivariate analysis. On the contrary, another large study found preoperative sepsis as a risk factor on multivariate analysis in addition.9 Shen et al.20 observed higher incidence of haemorrhage in the presence of pancreatic necrosis. A recent study has found 29.5% incidence of haemorrhage in the presence of inected necrosis.12 In the present study, we observed 29.7% (14 out of 47) incidence in the presence of infected necrosis. Infected necrosis and presence of sepsis were the risk factors associated with the occurrence of haemorrhage on multivariate analysis.
Incidence of venous thrombosis in the present study was 12.5%, it was not an independent risk factor for bleeding. Others have reported incidence of venous thrombosis ranging from 2-23%.5,11,21 Incidence of bleeding was higher amongst those who had a delayed admission to a teritiary care facility. Sharma et al.7 also observed similar findings. Haemorrhage is usually a late event in the course of illness.5 A recent study by our group has shown poor overall outcome of patients presenting beyond one week of onset of illness.3 The management of these patients is challenging due to the presence of peripancreatic inflammatory process, ongoing sepsis, poor physiological status as a result of prolonged illness and inability to exactly localize the source of bleeding. Presence of pseudoaneurysms as localized on angiography is a favorable situation as algorithm based directed therapy can be successfully carried out in this situation.13 We reported splenic artery to be commonest site for pseudoaneurysm. Others have also observed similar findings.5-7,9,14-16 We reported pseudoaneurysms as the cause of haemorrhage in one- third of the cases. Others have reported haemorrhage due to pseudoaneurysms in 10%11 and 18%7 cases. A recent review has reported pseudoaneurysms as the cause of acute haemorrhage in 60% cases.5
However, the exact management of non localized bleed still remains to be elucidated. A recent review has reported 20% incidence of capillary and venous bleeding.5,6 In the present study, bleeding could not be precisely localized in seven (30%) of the patients. The cause is usually the slow diffuse venous or capillary oozing which is difficult to pin point. Those with major non localized have very limited surgical options and have a high mortality.
Concluding, the present study has proposed the classification system based on the nature, site, timing and severity of haemorrhage. Based on the classification, we have evolved the management algorithm to plan a treatment strategy.
REFERENCES
1. Working Group IAP/APA Acute Pancreatitis Guidelines. 2013; IAP/ APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology. 13(4 Suppl 2):e1–e15. DOI: 10.1016/j.pan.2013.07.063. PMID: 24054878.
2. Manrai M, Kochhar R, Gupta V, Yadav TD, Dhaka N, Kalra N, et al. 2018; Outcome of acute pancreatic and peripancreatic collections occurring in patients with acute pancreatitis. Ann Surg. 267:357–363. DOI: 10.1097/SLA.0000000000002065. PMID: 27805963.
3. Mallick B, Dhaka N, Sharma V, Malik S, Sinha SK, Dutta U, et al. 2019; Impact of timing of presentation of acute pancreatitis to a tertiary care centre on the outcome. Pancreatology. 19:143–148. DOI: 10.1016/j.pan.2018.10.005. PMID: 30366676.
4. Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et al. 2013; Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut. 62:102–111. DOI: 10.1136/gutjnl-2012-302779. PMID: 23100216.
5. Evans RP, Mourad MM, Pall G, Fisher SG, Bramhall SR. 2017; Pancreatitis: preventing catastrophic haemorrhage. World J Gastroenterol. 23:5460–5468. DOI: 10.3748/wjg.v23.i30.5460. PMID: 28852306. PMCID: PMC5558110.
6. Andersson E, Ansari D, Andersson R. 2010; Major haemorrhagic complications of acute pancreatitis. Br J Surg. 97:1379–1384. DOI: 10.1002/bjs.7113. PMID: 20564308.
7. Sharma PK, Madan K, Garg PK. 2008; Hemorrhage in acute pancreatitis: should gastrointestinal bleeding be considered an organ failure? Pancreas. 36:141–145. DOI: 10.1097/MPA.0b013e318158466e. PMID: 18376304.
8. Flati G, Andrén-Sandberg A, La Pinta M, Porowska B, Carboni M. 2003; Potentially fatal bleeding in acute pancreatitis: pathophysiology, prevention, and treatment. Pancreas. 26:8–14. DOI: 10.1097/00006676-200301000-00002. PMID: 12499910.
9. Wei AL, Guo Q, Wang MJ, Hu WM, Zhang ZD. 2016; Early complications after interventions in patients with acute pancreatitis. World J Gastroenterol. 22:2828–2836. DOI: 10.3748/wjg.v22.i9.2828. PMID: 26973421. PMCID: PMC4778005.
10. Ammori BJ, Madan M, Alexander DJ. 1998; Haemorrhagic complications of pancreatitis: presentation, diagnosis and management. Ann R Coll Surg Engl. 80:316–325. PMID: 9849330. PMCID: PMC2503105.
11. Balthazar EJ, Fisher LA. 2001; Hemorrhagic complications of pancreatitis: radiologic evaluation with emphasis on CT imaging. Pancreatology. 1:306–313. DOI: 10.1159/000055829. PMID: 12120209.
12. Labarca E, Zubia F, Maraví-Poma E, Martinez F. EPAMI Group. 2018; Early predictors of abdominal hemorrhage among critically ill patients with pancreatitis: a prospective cohort study. Pancreas. 47:1027–1032. DOI: 10.1097/MPA.0000000000001135. PMID: 30045171.
13. Gupta V, Irrinki S, Sakaray YR, Moond V, Yadav TD, Kochhar R, et al. 2018; Treatment strategies for bleeding from gastroduodenal artery pseudoaneurysms complicating the course of chronic pancreatitis-a case series of 10 patients. Indian J Gastroenterol. 37:457–463. DOI: 10.1007/s12664-018-0897-y. PMID: 30374751.
14. Bergert H, Hinterseher I, Kersting S, Leonhardt J, Bloomenthal A, Saeger HD. 2005; Management and outcome of hemorrhage due to arterial pseudoaneurysms in pancreatitis. Surgery. 137:323–328. DOI: 10.1016/j.surg.2004.10.009. PMID: 15746787.
15. Mendelson RM, Anderson J, Marshall M, Ramsay D. 2005; Vascular complications of pancreatitis. ANZ J Surg. 75:1073–1079. DOI: 10.1111/j.1445-2197.2005.03607.x. PMID: 16398814.
16. Udd M, Leppäniemi AK, Bidel S, Keto P, Roth WD, Haapiainen RK. 2007; Treatment of bleeding pseudoaneurysms in patients with chronic pancreatitis. World J Surg. 31:504–510. DOI: 10.1007/s00268-006-0209-z. PMID: 17322972.
17. Balthazar EJ. 2002; Complications of acute pancreatitis: clinical and CT evaluation. Radiol Clin North Am. 40:1211–1227. DOI: 10.1016/S0033-8389(02)00043-X. PMID: 12479707.
18. Balachandra S, Siriwardena AK. 2005; Systematic appraisal of the management of the major vascular complications of pancreatitis. Am J Surg. 190:489–495. DOI: 10.1016/j.amjsurg.2005.03.009. PMID: 16105542.
19. Tang MY, Chen TW, Bollen TL, Wang YX, Xue HD, Jin ZY, et al. 2018; MR imaging of hemorrhage associated with acute pancreatitis. Pancreatology. 18:363–369. DOI: 10.1016/j.pan.2018.03.004. PMID: 29615311.
20. Shen X, Sun J, Zhang J, Ke L, Tong Z, Li G, et al. 2015; Risk factors and outcome for massive intra-abdominal bleeding among patients with infected necrotizing pancreatitis. Medicine (Baltimore). 94:e1172. DOI: 10.1097/MD.0000000000001172. PMID: 26181564. PMCID: PMC4617064.
21. Law NM, Freeman ML. 2003; Emergency complications of acute and chronic pancreatitis. Gastroenterol Clin North Am. 32:1169–1194. ix. DOI: 10.1016/S0889-8553(03)00089-X. PMID: 14696302.
FIGURES AND TABLES
Table 1
Parameter | Entire cohort (n=183) | With haemorrhage (n=24) | With-out haemorrhage (n=159) | Univariate p-value | Multivariate p-value | OR (95% confidence interval) |
---|---|---|---|---|---|---|
Age (years) | 39.58±12.95 | 39.17±16.41 (15-90) | 39.64±12.44 (13-70) | 0.507 | ||
Sex ratio (M:F) | 2.58:1 | 3:1 | 2.5:1 | 0.416 | ||
Etiology | 0.934 | |||||
Alcohol | 92 | 14 | 78 | |||
Biliary | 50 | 5 | 45 | |||
Other | 41 | 5 | 36 | |||
Interval b/w onset and admission* (days) | 12.51±17.09 | 24.0±30.28 | 10.06±13.41 | 0.037 | 0.792 | 1.02 (0,98-1.06) |
Comorbidities | 28 | 1 | 27 | 0.584 | ||
APACHEII | 6.09±4.13 | 6.9±5 | 5.8±3.7 | 0.022 | 0.367 | 0.91 (0.74-1.10) |
Mean number of organs failure** | 0.76 | 1.125 | 0.7 | 0.008 | 0.064 | 1.13 (0.54-2.37) |
Presence of collections | 85 | 14 | 71 | 0.417 | ||
Infected necrosis | 47 | 14 | 33 | 0.000 | 0.00 | 11.82(2.40-58.29) |
Bacterial sepsis | 45 | 10 | 35 | 0.037 | 0.08 | 2.15 (0.37-12.64) |
Fungal sepsis | 12 | 4 | 8 | 0.032 | 0.03 | 3.73 (1.03-13.50) |
Venous thrombosis | 21 | 5 | 16 | 0.12 | ||
CTA pseudoaneurysm | 9 | 8 | 1 | 0.000 | 0.00 | 113 (7.01-1801) |
Need for PCD | 96 | 11 | 85 | 0.485 | ||
Need for surgical intervention | 32 | 12 | 20 | 0.000 | 0.058 | 2.50 (0.55-11.28) |
Mortality | 27 | 10 | 17 | 0.000 | 0.014 | 5.72 (0.94-34.95) |
ICU stay | 5.80+5.61 | 7.35+7.93 | 5.35+5.20 | 0.000 | 0.481 | 1.58 (0.1-24.78) |
Hospital stay | 18.91+12.82 | 21.96+15.73 | 18.48+12.7 | 0.388 |
Table 2
Parameter | Luminal haemorrhage (n=12) | Abdominal haemorrhage (n=12) | p-value |
---|---|---|---|
Age | 38.83±12.48 | 39.50±20.2 | 0.923 |
Sex ratio- M:F | 3:1 | 3:1 | 1.00 |
Interval between onset and bleed* | 23.0±31.2 | 31.8±20.9 | 0.055 |
APACHE II | 7.7±4.1 | 7.6±6.7 | 0.359 |
CTSI | 8.5±1.16 | 9.42±1.16 | 0.046 |
Mean number of organ failure** | 1.5 | 0.75 | 0.261 |
Venous thrombosis | 3 (25%) | 2 (16.66%) | 0.384 |
Pseudoaneurysm | 4 (33.3%) | 4 (33.3%) | 1.000 |
Infected necrosis | 6 | 8 | 0.198 |
Sepsis | 4 | 3 | 0.332 |
Need for surgery | 3 (25%) | 9 (75%) | 0.041 |
Mortality | 3 (33.3%) | 6 (50%) | 0.206 |
Hospital stay | 23.42±18.44 | 20.50±13.13 | 0.954 |
ICU stay | 7.38±3.58 | 7.33±10 | 0.174 |
Table 3
Parameters | Major haemorrhage (n=13) | Minor haemorrhage (n=11) | p-value |
---|---|---|---|
Age | 41.54±17.34 | 36.36±15.64 | 0.455 |
Sex ratio M:F | 1:5.5 | 1:1.75 | |
Interval between onset and bleed* | 34.54±32.02 | 22.55±28 | 0.163 |
APACHE II | 8.27±5.2 | 6.38±4.92 | 0.359 |
CTSI | 9.18±1.16 | 8.77±1.30 | 0.381 |
Mean number of organ failure** | 1.69 | 0.62 | 0.043 |
Venous thrombosis | 1 (7.4%) | 4 (36.3%) | 0.243 |
Pseudoaneurysm | 7 (53.8%) | 1 (9.1%) | 0.020 |
Infected necrosis | 7 | 6 | 1.000 |
Sepsis | 4 | 2 | 0.691 |
Need for surgery | 9 (69.2) | 3 (27.3) | 0.041 |
Mortality | 6 (46.2%) | 3 (27.2%) | 0.422 |
Hospital stay | 21.77±13.14 | 22.18±19.03 | 0.685 |
ICU stay | 8.7±10.44 | 6±4.37 | 0.909 |
Table 4
Parameters | De-novo haemorrhage (n=16) | Post-surgical haemorrhage (n=8) | p-value |
---|---|---|---|
Age | 39.13±18.15 | 39.25±13.47 | 0.829 |
Sex ratio M:F | 12:4 | 6:2 | 1.000 |
Interval between onset and bleed* | 32.06±35.56 | 23±15 | 0.806 |
APACHE II | 7.19±5.2 | 7.38±4.95 | 0.684 |
CTSI | 8.88±1.14 | 9.13±1.45 | 0.467 |
Mean number of organ failure** | 12 (75%) | 3 (37.5%) | 0.368 |
Venous thrombosis | 4 (25%) | 1 (12.5%) | 0.603 |
Pseudoaneurysm | 5 | 3 | 0.127 |
Infected necrosis | 7 | 7 | 0.079 |
Sepsis | 4 | 3 | 0.463 |
Mortality | 4 (25%) | 5 (62.5%) | 0.159 |
Hospital stay | 23.31±16.51 | 19.25±14.70 | 0.624 |
ICU stay | 5.62±3.9 | 10.57±12.2 | 0.604 |